July 14 (Bloomberg) -- Ira Loss, senior health-policy analyst at Washington Analysis Corp., talks with Bloomberg's Peter Cook about the outlook for a U.S. Food and Drug Administration advisory panel vote on GlaxoSmithKline Plc's diabetes drug Avandia. The FDA advisory panel decided today that Avandia increases the risk of cardiovascular side effects. The panel meeting in Gaithersburg, Maryland, will vote later on mortality and whether Avandia should be recalled. (Source: Bloomberg)
Просмотров: 210 Bloomberg
The U.S. and European drug regulatory agencies recently issued rulings that restrict the use of the diabetes drug Avandia, which studies show increase the risk of heart attack and stroke as it controls blood sugar levels. VOA's Vidushi Sinha has more.
Просмотров: 225 VOA News
The European Medicines Agency on Friday said it's starting a review of the GlaxoSmithKline (GSK) diabetes drug Avandia over the heart risks involved in taking the medication, MarketWatch reports. The agency's Committee for Medicinal Products for Human Use will be discussing between July 19 and July 22 recent data linking GSK's Avandia to heart risks and whether the drug should be revoked, suspended or changed. The panel will look at June studies linking Avandia to the risk of stroke and heart failure in elderly Medicare patients and a "meta-analysis" of the cardiovascular risks. FDA advisory committees are looking at the same issue on July 13 and July 14. Avandia safety concerns have been around since at least 2007, according to the report.
Просмотров: 775 TradeTheTrend
Keith D. Griffin
Просмотров: 187 SuperLawyers
When it comes to lying, no industry does it better than the pharmaceutical industry. By faking test results, hiding unfavorable results, and paying off the right people, pharmaceutical companies have been able to push dangerous drugs onto American consumers, who pay for the company's negligence with their own health and sometimes with their own lies. Mike Papantonio talks with investigative journalist Paul Thacker, who's uncovered yet another instance of pharmaceutical company cover ups, this time with Glaxo Smith Kline's blockbuster drug Avandia.
Просмотров: 1092 The Ring of Fire
A study in the Journal of the American Medical Association (JAMA) Monday links GlaxoSmithKline Plc's (NYSE:GSK) Avandia diabetes drug to heart risk. Avandia is a commonly prescribed diabetes drug that, according to the study, increases the risks of heart disease, stroke and death. The study examined about a quarter million Type 2 diabetes patients taking two different diabetes drugs, and found that Avandia lead to a 25% greater risk of heart failure versus the competing drug, Actos; a 27% greater risk of stroke was also evident in Avandia patients. Avandia has been criticized in the past for harmful side effects - a New England Journal of Medicine study suggested the same findings as the JAMA study in 2007, which lead to a Food and Drug Administration (FDA) investigation. Doctors who took part in the JAMA study are wondering why diabetic patients are being prescribed Avandia, given there are other drugs on the market with less harmful side effects. "What we're reporting in this study today was available to the FDA in 2007," said Dr. David Graham from the Maryland-based Center for Drug Evaluation and Research at the FDA. "That keeps unsafe drugs on the market and patients are the ones who suffer," added Graham. Director of the Cardiac Intensive Care Unit at St. Louis-based Washington University School of Medicine, Dr. Richard Bach, disagrees, saying, "I think the data is inconclusive. A physician should consider the weight of that evidence and the fact that it's been discrepant in various studies. I would not say that the totality of evidence weighs in to say that the drug always has harm." Dr. Bach admits that he has not yet read the JAMA study, and pointed to a 2007 FDA safety alert that analyzed 42 studies suggesting that Avandia increased cardiovascular problems in patients, whereas others at the time touted the drug as safe. Shares of GlaxoSmithKline are trading down 0.55% Monday afternoon at $34.42.
Просмотров: 1077 TradeTheTrend
Some people who have type 2 diabetes can achieve their target blood sugar levels with diet and exercise alone, but many also need diabetes medications or insulin therapy. The decision about which medications are best depends on many factors, including your blood sugar level and any other health problems you have. Your doctor might even combine drugs from different classes to help you control your blood sugar in several different ways. 1. Metformin Generally, metformin is the first medication prescribed for type 2 diabetes. It works by improving the sensitivity of your body tissues to insulin so that your body uses insulin more effectively. Metformin also lowers glucose production in the liver. Metformin may not lower blood sugar enough on its own. Your doctor will also recommend lifestyle changes, such as losing weight and becoming more active. 2. Meglitinides These medications work like sulfonylureas by stimulating the pancreas to secrete more insulin, but they're faster acting, and the duration of their effect in the body is shorter. They also have a risk of causing low blood sugar, but this risk is lower than with sulfonylureas. Weight gain is a possibility with this class of medications as well. Examples include repaglinide (Prandin) and nateglinide (Starlix). 3. Thiazolidinediones Like metformin, these medications make the body's tissues more sensitive to insulin. This class of medications has been linked to weight gain and other more-serious side effects, such as an increased risk of heart failure and fractures. Because of these risks, these medications generally aren't a first-choice treatment. Rosiglitazone (Avandia) and pioglitazone (Actos) are examples of thiazolidinediones. 4. Sulfonylureas These medications help your body secrete more insulin. Examples of medications in this class include glyburide (DiaBeta, Glynase), glipizide (Glucotrol) and glimepiride (Amaryl). Possible side effects include low blood sugar and weight gain. 5. GLP-1 receptor agonists These medications slow digestion and help lower blood sugar levels, though not as much as sulfonylureas. Their use is often associated with some weight loss. This class of medications isn't recommended for use by itself. Exenatide (Byetta) and liraglutide (Victoza) are examples of GLP-1 receptor agonists. Possible side effects include nausea and an increased risk of pancreatitis. 6. SGLT2 inhibitors These are the newest diabetes drugs on the market. They work by preventing the kidneys from reabsorbing sugar into the blood. Instead, the sugar is excreted in the urine. Examples include canagliflozin (Invokana) and dapagliflozin (Farxiga). Side effects may include yeast infections and urinary tract infections, increased urination and hypotension. 7. DPP-4 inhibitors These medications help reduce blood sugar levels, but tend to have a modest effect. They don't cause weight gain. Examples of these medications are sitagliptin (Januvia), saxagliptin (Onglyza) and linagliptin (Tradjenta).
Просмотров: 283295 Diabetes zone
"GlaxoSmithKline (NYSE:GSK) shares are trading 1.15% lower at $39.69 after the FDA said that there should be ""significantly restricted access"" to its diabetes drug Avandia and the EMA recommended that the drug be suspended and taken off the market. On the European Medicines Agency website, a statement was issued saying, ""The European Medicines Agency today recommended the suspension of the marketing authorisations for the rosiglitazone-containing anti-diabetes medicines Avandia, Avandamet and Avaglim. These medicines will stop being available in Europe within the next few months."" The agency added, ""Since its first authorisation, rosiglitazone has been recognised to be associated with fluid retention and increased risk of heart failure and its cardiovascular safety has always been kept under close review. Consequently, the use of rosiglitazone was restricted to a second-line treatment and contra-indicated in patients with heart failure or a history of heart failure when it was first granted a marketing authorisation as Avandia in 2000."" According to the Food and Drug Administration's website, ""The U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia."" SmarTrend is bullish on shares of GlaxoSmithKline and our subscribers were alerted to buy on July 14, 2010 at $36.15. The stock has risen 9.5% since the alert was issued."
Просмотров: 165 TradeTheTrend
Brown and Crouppen Law Firm is a full service personal injury, accident, and disability law firm based in St. Louis, Missouri, and serving clients nationwide. If you have a legal question, please feel free to call us. For faster service, you can call our YouTube referral hotline - (888) 539-1958. We are here to answer your questions 24/7. You can also visit our site - http://www.GetBC.com, where you can web chat with one of intake professionals. There is never any obligation. We are here to help you. We represent people in the following legal areas: Personal Injury Motor Vehicle Accidents Workers' Compensation Defective Products Dangerous Drugs Mesothelioma/Asbestos Medical Malpractice Premises Liability Social Security Disability Railroad Injuries (FELA) Self Help Resources Brown and Crouppen Law Firm Locations Saint Louis, MO Headquarters Brown & Crouppen Law Firm 211 North Broadway, Suite 1600 One Metropolitan Square Saint Louis, MO 63102 Telephone: 314-222-7711 M-F 8:30 a.m. - 5 p.m. - View Map Our downtown St. Louis office is our headquaters location, and serves the greater St. Louis metropolitan area, as well being home to our national campaigns. Kansas City, MO Office Brown & Crouppen Law Firm 2107 Grand Blvd, Ste. C1 Kansas City, MO 64108 Telephone: 816-521-6444 M-F 9 a.m. - 5 p.m. - View Map Our Kansas City, MO office serves the metropolitan Kansas City area including Leavenworth, Liberty, Excelsior Springs, Gladstone, Shawnee, Lenexa, Olathe, Belton, Grandview, Blue Springs, Overland Park, Lee's Summit, Leawood and Independence. O'Fallon, MO Office Brown & Crouppen Law Firm 110 Laura K Drive O'Fallon, MO 63366 Telephone: 636-200-6043 By appointment only - View Map Our O'Fallon, MO office serves the greater O'Fallon area including Warrenton, Wentzville, Lake St. Louis, St. Peters, Cottlevlle and Troy. Fairview Heights, IL Office Brown & Crouppen Law Firm 5200 N. Illinois, Ste. 104 Fairview Heights, IL 62208 Telephone: 618-216-7100 M-F 7:00 a.m. - 11:00 a.m. (closed 11:00 - 12:00) 12:00 p.m. - 3:30 p.m. - View Map Our Fairview Heights, IL office serves the greater Fairview Heights area including Edwardsville, Troy, Glen Carbon, Maryville, Collinsville, Caseyville, East St. Louis, Lebanon, Belleville, O'Fallon, Shiloh, Mascoutah, Millstadt, and Columbia. Saint Charles, MO Office Brown & Crouppen Law Firm 1361 Bass Pro Drive St. Charles, MO 63301 Three Flags Center Telephone: 636-200-6045 M-F 8:30 a.m. - 12:00 p.m. (closed 12:00 - 1:00) 1:00 p.m. - 5:00 p.m. - View Map Our St. Charles, MO office serves the greater St. Charles area including New Town, Hazelwood, St. Ann, Maryland Heights, Creve Coeur, Bridgeton, and Florissant. Arnold, MO Office Brown & Crouppen Law Firm 866 Arnold Commons Arnold, MO 63010 Telephone: 636-200-6046 M-F 8:30 a.m. - 11:30 a.m. (closed 11:30 - 12:30) 12:30 p.m. - 5:00 p.m. - View Map Our Arnold, MO office serves the greater Arnold area including Mehlville, Oakville, Fenton, Barnhart, Pevely, Herculaneum, Festus, Crystal City, House Springs, and High Ridge. Washington, MO Office Brown & Crouppen Law Firm 3014 Phoenix Center Drive Washington, MO 63090 Telephone: 636-200-6047 M-F 8:30 a.m. - 5 p.m. - View Map Our Washington, MO office serves the greater Washington area including Weldon Spring, Defiance, New Haven, Wildwood, Pacific, Villa Ridge, Gray Summit, Eureka, Union, Labadie, Sullivan, St. Clair, and Herman.
Просмотров: 46 Brown and Crouppen Law Firm
The prescription diabetes drug, Avandia, has received a lot of attention in the news after research suggested it increases the cardiovascular risks for patients taking it. Gundersen Lutheran endocrinologist Mary Frohnauer, MD was on WXOW News 19 to talk about what patients should do if they are taking this drug.
Просмотров: 181 Gundersen Health System
http://www.medpagetoday.com CHICAGO -- In the month since the New England Journal of Medicine published a meta-analysis that linked use of rosiglitazone (Avandia) to an increased risk of myocardial infarction, controversy surrounding the use of this popular diabetes drug has continued unabated. Earlier this month a Congressional hearing investigated the FDA's handling of rosiglitazone and several medical journals have weighed in with editorials on the controversy. The American Diabetes Association addressed the issue at a special symposium. MedPage Today examines both sides of the controversy in this exclusive report from Multimedia Producer Greg Laub, with Crystal Phend, MedPage Today staff writer and Neil Osterweil, MedPage Today Senior Associate Editor. Medpage Today: http://medpagetoday.com Online CME - Continuing medical education: http://www.medpagetoday.com/cme/ Latest medical news: http://www.medpagetoday.com/latest/ The MedPage Today app: iOS: https://goo.gl/JKrkHq Android: https://play.google.com/store/apps/details?id=com.medpagetoday.medpage MedPage Today Youtube Channel: https://www.youtube.com/user/MedPageToday Medpage Today on Facebook: https://www.facebook.com/MedPageToday
Просмотров: 804 MedPage Today
Welcome! This information has been taken from Mike Adams website. GlaxoSmithKline, maker of the diabetes drug Avandia, knew the drug was linked to tens of thousands of heart attacks but went out of its way to hide this information from the public, says a 334-page report just released by the Senate Finance Committee. This report also accuses the FDA of betraying the public trust, explaining that FDA bureaucrats intentionally dismissed safety concerns found by the agency's own scientists. The report says that Big Pharma's drugs "put public safety at risk because the FDA has been too cozy with drug makers and has been regularly outmaneuvered by companies that have a financial interest in downplaying or under-exploring potential safety risks." Sales of Avandia were $3.2 billion (yes, billion) in 2006. According to a statistical analysis in the report, if all the diabetics currently taking Avandia were put on a "safer" drug, it would avert 500 heart attacks and 300 cases of heart failure every month in the United States alone. Presently, hundreds of thousands of Americans are still taking this drug, and hundreds will continue to die each month as a result, according to the report estimates. This report, championed by U.S. Senators Grassley and Baucus, is the result of investigators pouring through more than 250,000 pages of documentation gathered from GlaxoSmithKline and the FDA. The document reveals some rather startling facts about the dangers of Avandia, including evidence from the FDA's own scientists who concluded that Avandia was associated with 83,000 heart attacks. I have found that playing God with out bodies using foreign drugs will not improve our quality and quantity of life on this gorgeous planet. My Q: What environmental challenge has caused your body to create type II diabetes? What distinction could you make right NOW to change your direction and improve your health? Mike Adams continues Are you kidding me? A drug company hid data that its high-profit drug was linked to increased risk of heart attacks? A drug company intimidated physicians and got away with hoodwinking the public while raking in billions of dollars in sales for a drug that the FDA's own scientists said should be pulled from the market? Sounds like business as usual at the FDA, the "sweep it under the rug" division of the pharmaceutical industry. Once again, Dr David Graham turns out to be the sharpest guy in the room while having the courage to tell the truth even when surrounded by an agency full of morons and criminals. The drug industry must hate this guy. But they can't get rid of him because he's one of the very few scientists in the FDA who is actually committed to protecting the public. Gee, what a concept, huh? The FDA as a whole abandoned that idea so long ago that virtually nobody there even remembers what it means. Protect the public? What do you mean? As in, lose profits by banning dangerous drugs that just happen to be making big money? That's unthinkable at the FDA as we know it today. The agency exists to promote pharmaceuticals, not to limit their sales just because a hundred thousand people happen to drop dead each year from taking FDA-approved drugs. When it comes to safety vs. profits, the FDA chooses profits for Big Pharma time and time again. Do the math on this: If Avandia is linked to 83,000 heart attacks, and if roughly 50% of those are fatal (that's just an estimate), then Avandia could conceivably be the cause of 40,000 deaths. The terrorist attacks of 9/11 killed roughly 3,000 Americans, and yet just one drug that has been mysteriously kept on the market by the FDA appears to have killed more than ten times as many Americans as the terrorists. So what does that make the FDA? More dangerous than the terrorists, of course! Over to you and find humour in your daily thoughts today. Sending love
Просмотров: 1494 Magnus Mulliner
Avandia, the diabetes drug, has been significantly restricted by the FDA due to possible heart injury increase. Have you been injured by the drug, Avandia? Call Peterson & Associates, P.C. at 877-378-4442 or visit http://www.avandiaheartdamage.com for an immediate case review and answers to your questions. We are dedicated to protecting you.
Просмотров: 1582 mthompson115
Feb. 22 (Bloomberg) -- Bloomberg's Peter Cook reports on GlaxoSmithKline Plc's Avandia diabetes-treatment drug. Shares of the drugmaker fell after U.S. Senators released a report showing that safety reviewers had urged the U.S. Food and Drug Administration to take Avandia off the market because it caused an increased risk of heart attacks. (Source: Bloomberg)
Просмотров: 402 Bloomberg
Hi, this is Larry Hobbs @ FatNews.com. http://fatnews.com/ https://twitter.com/fatnews Prof. Peter Gøetsche, MD notes that... The RECORD trial of the diabetes drug Rosiglitazone (Avandia) was terribly manipulated by GlaxoSmithKline. On July 9, 2010, an article in the New York Times titled, "Caustic Government Report Deals Blow to Diabetes Drug" revealed that Dr. Thomas Marciniak, a reviewer at the US Food and Drug Administration (FDA), found a dozen instances in which patients taking Rosiglitazone (Avandia) suffered serious heart problems that were not counted in the study’s tally of adverse events. http://www.nytimes.com/2010/07/10/health/10diabetes.html The article also notes that, "It [ Rosiglitazone (Avandia) ] has been shown to increase the risks of bone fractures and to cause swelling that can lead to heart failure and eye problems." The article also notes that "Dr. Jerome P. Kassirer, a former editor of The New England Journal, said the Record trial raised the question “whether the entire system is corrupt.”" At the beginning of the video, Prof. Peter Gøetsche, MD says, “What the drug industry publishes, even in the New England Journal of Medicine, should be viewed as an ADVERTISEMENT and nothing else.” https://www.youtube.com/watch?v=3XEDzhjW9fU The video is titled: “HAI Europe - Dr. Peter Gøtzsche - why it is so important to have access to all medical research data” Prof. Peter Gøetsche, MD cofounded the Cochrane Collaboration in 1993. It is a non-profit organization of scientists around the world who analyze data to try and figure out the truth about drugs and other health topics. Prof. Peter Gøetsche, MD's book "Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare" http://www.amazon.com/Deadly-Medicines-Organised-Crime-Healthcare/dp/1846198844/
Просмотров: 319 Fatnews
Study published by New England Journal of Medicine revealed that Avandia is associated with significant increase in risk of heart attack. If you or a loved one used Avandia & suffered heart attack, stroke, or sudden death, you may have a legal claim.
Просмотров: 1271 alexanderhawes1
http://www.craigswapp.com/practice-areas/product-liability/avandia/ - If you or a loved one has used the diabetes drug Avandia and suffered a stroke, heart attack/disease, or even death, please contact our law firm right away to preserve your rights in a lawsuit. It is estimated that Avandia has caused over 47,000 cardiovascular events in patients over the past few years causing the FDA to issue a safety alert to doctors.
Просмотров: 393 CraigSwappAssoc
If you have diabetes and have taken the drug Avandia, you may be entitled to a cash award. If you or someone you know has suffered a heart attack, stroke, or even died while taking Avandia, call attorney Jim S. Adler right now. "If you or a loved one has taken this drug, Call me Right Now!" 713-777-4000 or 1-800-2HAMMER
Просмотров: 10071 jimadlerhouston
A county in the U.S. state of California is suing GlaxoSmithKline, the maker of Avandia, a controversial diabetes drug. The lawsuit was spurred by a report on the drug released by the U.S. Senate last week (March 22). That report accused the drug company of withholding information about side effects of serious heart problems, including death. At issue now is whether Avandia should be taken off the market. VOA's Carol Pearson has more.
Просмотров: 1359 VOA News
Shares of GlaxoSmithKline (GSK) are down after Bloomberg, citing a lawyer for the patients, reported that the drug maker is set to resolve 1,000 more lawsuits over medicines, including the diabetes drug Avandia. Glaxo is in settlement talks with attorneys for an estimated 1,000 former Avandia users. Glaxo shares are down 0.42%, or $0.18, to $43.06.
Просмотров: 374 FinancialNewsOnline
Dr. Wayne Evron from West Penn Hospital's Joslin Diabetes Center talks to KDKA-TV Pittsburgh about the loss of Avandia as a medication for patients with diabetes and what alternative medications may be helpful.
Просмотров: 148 Allegheny Health Network
Avandia Lawsuit info: http://www.adrugrecall.com/avandia/avandia.html Avandia® has been linked to serious side effects, including heart attack, stroke and congestive heart failure. The risk is so serious that the FDA has issued a national warning and has restricted use of Avandia® to diabetic patients who are already taking the drug and to those who have tried other medications without success. Patients who are harmed by the adverse effects of Avandia® can seek compensation for their injuries and loss. If you or someone you love has suffered a heart attack, stroke, congestive heart failure, or another complication and have a history of Avandia® use, contact us for a free evaluation of your case.
Просмотров: 424 aDrugRecall
Avandia Drug Lawsuit Attorneys - http://www.tellrobert.com/Avandia/ If you, or someone you care about, has had heart problems related to taking avandia, you can contact our law firm for a free evaluation by: Contact our Attorneys so we can evaluate your claim Calling toll free 1-855-TELLROBERT. Our phones answer 24 hours a day 7 days a week Our law firm will evaluate your claim free of charge and advise you on your legal rights to collect compensation. There is no obligation to use our services, and "YOU PAY NO FEE UNLESS THERE IS MONEY FROM YOUR CASE". Let Attorney Robert J. Fenstersheib & Associates represent you in the Avandia Class Action Lawsuit.
Просмотров: 736 Robert Fenstersheib
The type-2 diabetes medication Avandia has been linked to an increased risk of cardiac related ailments, including heart attack and stroke.
Просмотров: 1480 ReichandBinstockLLP
A study suggested that GlaxoSmithKline Plc's (GSK) Avandia drug assisted in preventing onset of diabetes when given in a low dose with another drug, Bloomberg reported. The treatment may help patients without raising heart attack risk, according to the company-sponsored study, the report said. GlaxoSmithKline shares are up $0.19, or 0.55%, to $35.00.
Просмотров: 212 TradeTheTrend
Dr. Steven Nissen, whose 2007 meta-analysis sparked the 6-year investigation into rosiglitazone's cardiovascular safety, responds to the Food and Drug Administration's panel hearing on the readjudication of the RECORD trial. See the related story on Clinical Endocrinology News at http://tinyurl.com/lalowe6
Просмотров: 609 MDedge: news and insights for busy physicians
Attention diabetics if you or a loved has suffered a heart attack, stroke or even died while taking the diabetes drug Avandia, call attorney Gordon McKernan Right Now. If you or a loved have taken this drug and were injured call me right now you may be entitled to financial compensation. Get Gordon! Get Your Lawyer! If you have taken the diabetes drug and were injured call 1.800.546.2350 or visit our website at McKernanLawFirm.com
Просмотров: 3949 Gordon McKernan
July 14 (Bloomberg) -- Abraham Thomas, a member of a U.S. Food and Drug Administration advisory panel, talks with Bloomberg's Peter Cook about the panel's vote today to recommend GlaxoSmithKline Plc be allowed to continue selling its diabetes pill Avandia. Thomas was one of 12 FDA advisers who recommended Avandia be recalled because of heart risks. Seventeen of 32 advisers recommended new warnings or restrictions for Avandia. Three panel members said no changes were needed to the drug's prescribing information. Thomas speaks on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
Просмотров: 128 Bloomberg
July 14 (Bloomberg) -- Dr. Steven Nissen, chairman of cardiology at the Cleveland Clinic, talks with Margaret Brennan about the risks of GlaxoSmithKline Plc's diabetes drug, Avandia. The Food and Drug Administration is holding a meeting to examine the safety of the drug. Nissen, talks with Margaret Brennan on Bloomberg Television's "In Business." (Source: Bloomberg)
Просмотров: 171 Bloomberg
Sept. 23 (Bloomberg) -- Margaret Hamburg, commissioner of the Food and Drug Administration, talks with Bloomberg's Melissa Long and Michael Waldholz about the FDA's decision to restrict the use of GlaxoSmithKline Plc's Avandia. Avandia, once the world's best-selling diabetes drug, will be withdrawn in Europe and restricted in the U.S. after a three-year review of the medicine's heart risks. (Source: Bloomberg)
Просмотров: 114 Bloomberg
Drug maker GlaxoSmithKline $3 billion US in criminal and civil fines and plead guilty to misdemeanour criminal charges. Source: http://www.cbc.ca/news/health/story/2012/07/02/health-glaxosmithkline-fraud-settlement.html?cmp=rss FDA Warning http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm168828.htm Avandia Causing Heart problems http://www.cbc.ca/news/health/story/2010/09/23/avandia-diabetes-fda-europe-.html Add me on Facebook: http://www.fb.com/MaoistRebelNews Follow me on Twitter: http://twitter.com/MaoistRebelNews Read more news at: http://maoistrebelnews.wordpress.com/ Get More Commentary on Tumblr: http://maoistrebelnews.tumblr.com/ These videos are offered under private trust. Downloading constitutes acceptance of private trust terms. All private trust rights reserved.
Просмотров: 689 Jason Unruhe
http://www.terrybryant.com/drug-injury/ The FDA hasn't taken Avandia off the market yet as of Oct. 11,2010. However, the FDA advisory panel has voted to place more regulations on the drug. Contact Terry Bryant Accident & Injury Law today (713) 973-8888
Просмотров: 73 Terry Bryant
This week on the Beasley Allen Report, host Gibson Vance welcomes Beasley Allen lawyer Roger Smith. Roger is an attorney in the firm's Mass Torts section and is working on cases where people taking the Type II diabetes medication Actos have developed bladder cancer. Actos is manufactured by Takeda Pharmaceuticals. Recently, the FDA issued a warning saying people who have been taking the drug for a year or longer have an increased risk of developing bladder cancer. Interim results from a 10-year American study found long-term Actos users had 40 percent more bladder cancers than people who never took the drug. Bladder cancer kills about 15,000 people per year in the U.S. The drug also may be linked to congestive heart failure. In the past, Roger also worked on cases involving other diabetes drugs, Rezulin and Avandia, which were also linked to liver failure and congestive heart failure, respectively. Rezulin was taken off the market in 2000, and Avandia use was severely restricted in 2010. In addition to litigation surrounding Actos, Roger also is working on cases involving the antidepressant Zoloft, which has been linked to birth defects in babies born to mothers who took the drug during pregnancy. For more information about Actos visit: - http://www.rogersmith-law.com - http://www.actos-claim.com
Просмотров: 577 Beasley Allen
SAN DIEGO -- Bladder cancer risks aren't likely to send the diabetes drug pioglitazone (Actos) down the same path as rosiglitazone (Avandia), according to this exclusive InFocus report from the American Diabetes Association meeting. Medpage Today: http://medpagetoday.com Online CME - Continuing medical education: http://www.medpagetoday.com/cme/ Latest medical news: http://www.medpagetoday.com/latest/ The MedPage Today app: iOS: https://goo.gl/JKrkHq Android: https://play.google.com/store/apps/details?id=com.medpagetoday.medpage MedPage Today Youtube Channel: https://www.youtube.com/user/MedPageToday Medpage Today on Facebook: https://www.facebook.com/MedPageToday
Просмотров: 788 MedPage Today